Europe and America Small Molecules CDMO Market Size, Share, Growth, Trends, and Industry Analysis : By Service and Country
Europe and America Small Molecules CDMO Market size was valued at US$ 66,515.4 million in 2022 and is poised to grow at a CAGR of 5.9% from 2023-2029. A Contract Development and Manufacturing Organization (CDMO) is a company that serves the pharmaceutical sector by offering clients entire services ranging from drug development to manufacturing. The CDMOs offer holistic services that include external third-party initiatives as well as their knowledge and development. Pharmaceutical businesses have numerous problems in researching and manufacturing medication substances as pharmacological substances become more complicated. More rapid research and production are required to bring ideas to market faster, and many pharmaceutical businesses prioritize cost control or cost reduction.
Due to the high costs of equipment and the wide range of equipment required for sterile liquid dosage, liquid and semi-solid dosage, and solid dosage forms, partnering with a contract development and manufacturing organization (CDMO) or contract manufacturing organization (CMO) can help pharmaceutical companies bring new products or formulas to market without investing in additional infrastructure to support it. outsourcing tasks like manufacturing, production, or design. In the pharmaceutical industry, assembling and sending goods to contract manufacturers has become highly evident. Contract manufacturing provides associates with a supply of pharmaceutical products from clinical production to commercial manufacturing under Good Manufacturing Practices (GMP) manufacturing procedures, which has various advantages.
In addition, businesses no longer have to devote all of their time and resources to the production of pharmaceuticals and can instead concentrate on selling and marketing their products. Pharmaceutical firms collaborate with CDMOs to outsource medication development and production. Generally speaking, they handle all facets of drug development and production. Formulation, analytical services, mixing, coating, converting, packaging, serialization, and transportation are a few of the services provided by CDMOs. Because CDMOs are businesses that handle both the development and manufacture of a medicine and have the necessary knowledge in both areas, pharmaceutical companies that choose to work with them can start with more than just an idea and receive advice from pre-formulation and formulation development.
The growth is due to the rise in spending by the pharma companies on research and development of new and innovative drug molecule and dosage form innovation. Numerous establishments of small pharma and biotech companies in these regions propel the market growth in these region. Small pharma companies hold the intellectual property rights of the developing drug or dosage from and rest they prefer to outsource to save cost and also for lack of capital to set up full-fledged development lab or manufacturing unit.
|
Report Benchmarks |
Details |
|
Market Size in 2022 |
US$ 66,515.4 million |
|
By Services |
|
|
By Synthesis |
|
Download Free Sample Report
The Europe and America small molecules CDMO market size was valued at US$ 66,515.4 million in 2022 and is poised to grow at a CAGR of 5.9% from 2023-2029.
Lonza, Syngene International Limited, Pfizer Center One, Catalent, Inc., Esteve Química, Patheon (Thermo Fisher Scientific), Asymchem, Inc., Cambrex Corporation, Celanese Corporation, Evonik
| 1.Executive Summary |
| 2.Global Europe and America Small Molecules CDMO Market Introduction |
| 2.1.Global Europe and America Small Molecules CDMO Market - Taxonomy |
| 2.2.Global Europe and America Small Molecules CDMO Market - Definitions |
| 2.2.1.Services |
| 2.2.2.Synthesis |
| 3.Global Europe and America Small Molecules CDMO Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Product Landscape |
| 3.6. New Product Launches |
| 3.7. Impact of COVID 19 on Market |
| 4.Global Europe and America Small Molecules CDMO Market Analysis, 2019 - 2023 and Forecast 2024 - 2030 |
| 4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5.Global Europe and America Small Molecules CDMO Market By Services, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 5.1. Contract Development |
| 5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Contract Manufacturing |
| 5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 6.Global Europe and America Small Molecules CDMO Market By Synthesis, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 6.1. Fermentation/Purification |
| 6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Chemical Synthesis |
| 6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 7. Competition Landscape |
| 7.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
| 7.2.1.Lonza |
| 7.2.2.Syngene International Limited |
| 7.2.3.Pfizer Center One |
| 7.2.4.Catalent, Inc. |
| 7.2.5.Esteve Química |
| 7.2.6.Patheon (Thermo Fisher Scientific) |
| 7.2.7.Asymchem, Inc. |
| 7.2.8.Cambrex Corporation |
| 7.2.9.Celanese Corporation |
| 7.2.10.Evonik |
| 8. Research Methodology |
| 9. Appendix and Abbreviations |
Key Market Players
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthcare domain, encompassing pharmaceuticals, medical devices, and diagnostics. A graduate in Pharmacy, he possesses a strong foundation in the intricacies of the healthcare sector. He further enhanced his expertise by pursuing an MBA in Pharmaceuticals, equipping him with valuable business acumen. His analytical skills and market insights have contributed to strategic decision-making and enhanced market positioning for various healthcare organizations. Committed to driving innovation and excellence, Muni continues to seek opportunities to improve healthcare delivery through data-driven insights.
Download Free Sample
